Federal Reporting Requirements on Payments to Physicians: Impact on State Laws
With the enactment of the Patient Protection and Affordable Care Act in March 2010, all U.S. manufacturers of drugs, devices, biologics or medical supplies covered under government-funded insurance programs (i.e., Medicare, Medicaid and the State Children’s Health Insurance Program) are now required to report certain information to the federal Department of Health and Human Services (HHS) about any payment or gift, which are “transfers of value,” made to a physician or teaching hospital. HHS is required to make these data available to the public by posting them on a Web site. A Pew Prescription Project fact sheet describes how these federal reporting requirements affect comparable state disclosure laws.
Download the full PDF for more information.
- Date added:
- Nov 12, 2010
- Contact:
- Linda Paris, Tel: work202-540-6354
- Project:
- Pew Prescription Project
- Topic:
- Conflicts of Interest
Related Resources
Pew Comments on Centers for Medicaid and Medicare Services' Information Collection Activities Draft Guidance
The Pew Charitable Trusts appreciates this opportunity to submit comments to CMS's "Information Collection Activities" draft guidance. We suggest that both the research and non-research payment templates be modified in order to make it easier for consumers to identify which drugs, devices, biologicals, or medical supplies are associated with particular transfers of value.
More infoOne Step Closer to Medical Transparency: Pew's Analysis of the Final Rule for the Physician Payments Sunshine Act
On Feb. 1, 2013, the Centers for Medicare & Medicaid Services published the final rule guiding implementation of the Physician Payments Sunshine Act, which Congress passed as part of the Affordable Care Act in March 2010 to increase transparency in the relationships between physicians and drug and medical device makers. Here are some of the highlights. More info''Finding Out Who Pays Your Doctor''
"The Obama administration issued a new rule this month that requires the makers of prescription drugs and other medical products to disclose what they pay doctors for various purposes, like consulting or speaking on behalf of the manufacturer. This overdue rule adds much-needed weight to previous, more limited disclosure requirements."
More infoPew Commends Strong Transparency Rule for Physician-Industry Relationships
Allan Coukell, director of medical programs for The Pew Charitable Trusts, issued the following statement in response to the Centers for Medicare & Medicaid Services' final rule for implementing the Physician Payments Sunshine Act, which will bring transparency to the financial relationships between physicians and drug and medical device companies.
More info
